233
Participants
Start Date
November 30, 2016
Primary Completion Date
September 27, 2023
Study Completion Date
September 27, 2023
DW-MRI
DW-MRI combined with Contrast Enhanced MRI will be used to confirm the status of disappearing liver metastasis prior to surgery and will be compared to findings from either histopathology of resected lesions (Rubbia-Brandt Classification of Tumor regression grading) or follow-up imaging of lesions left behind (either CT scan or MRI) after surgery. MRI will be used during the follow-up period to confirm recurrences from a previous site of DLM.
Universitair Ziekenhuis Gent, Ghent
Institut Bergonie, Bordeaux
Centre Leon Berard, Lyon
OHSU Knight Cancer Institute, Portland
The University of Texas MD Anderson Cancer Center, Houston
Innsbruck Universitaetsklinik, Innsbruck
U.Z. Leuven - Campus Gasthuisberg, Leuven
Gustave Roussy, Villejuif
Chiba Cancer Center, Chiba
Gifu University Hospital, Gifu
Hiroshima Prefectural Hospital, Hiroshima
Hyogo College of Medicine, Hyōgo
Niigata Prefectural Cancer Center Hospital, Niigata
Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
Gunma Cancer Center, Ōta-ku
Jichi Medical University Saitama Medical Center, Saitama
Shizuoka Cancer Center, Shizuoka
National Cancer Center Hospital, Tokyo
Tokyo Medical and Dental University, Tokyo
Yamagata Prefectural Central Hospital, Yamagata
Kanagawa Cancer Center, Yokohama
Japan Clinical Oncology Group
OTHER
European Society of Surgical Oncology
OTHER
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK